Crisis Management

Kraft’s Uncertain Future

3 Oct , 2012  

This week I’m busy teaching in the Kellogg on Branding executive education program. Earlier today one of the participants asked me for my thoughts on the new Kraft Foods. This was a timely question; Kraft is in the news because the company just completed its split. The fast growing snacks business is now a distinct company called Mondelez. Kraft Foods is the North American grocery business, made up of brands like Miracle Whip, Grey Poupon and Cool Whip.

In theory the new Kraft should do well because the company can now focus on the grocery business. The combined company logically devoted resources and time to the high growth snacks business, neglecting the grocery side. With additional focus, the grocery business should do well, at least in theory.

The reality isn’t quite so simple. The new Kraft has two significant issues. First, Kraft hasn’t invested in its grocery brands for many years. Bloomberg recently reported that, according to a New York consulting firm, Kraft spent only 3% of sales on advertising over the past couple years. This is dramatically lower than General Mills (5.7%) and Kellogg (8.6%). With little investment the brands have eroded and now need innovation and great marketing. This spending will probably have a negative short-term ROI; building brands doesn’t deliver quick profits.

Second, Kraft plays in mature categories. There just isn’t a lot of growth in gelatin and macaroni and mayonnaise. One might wish for lots of growth, and proclaim that with innovation the category growth will appear. But that just isn’t likely to happen.

Kraft might have a bright future. The company could rebuild its brands, win over customers and deliver solid financial returns.

The key, however, is setting appropriate financial expectations. Kraft won’t be growing much, perhaps not at all. In the short run, profits should actually decline some as the company invests in marketing and innovation. But the dividend should be solid and results generally consistent and predictable.

The risk is that the new executive team tries to generate significant growth. The easy way to get growth in profits is to cut overhead, trim marketing, reduce product costs and spend on quick volume driving tactics like discounting. This formula will lead to long-term brand erosion and a difficult future.

Giving the new executive lots of stock options would be a very bad move; the stock market rewards quick profit growth. It is hard to resist the temptation to focus on short-term profits when there are options at stake. Hopefully the board sets the right incentives and Kraft’s new executive team builds the business, setting the stage for a bright future.


2 Responses

  1. Dr.P.G.K.Murthy says:

    An excellent paper. Brand building is a long term exercise

  2. Bob Killian says:

    Makes good sense. You do have to wonder if they’ll be able to attract or retain as much talent in this half of the divorced company.

    Bob Killian Killian Branding 322 South Green Chicago IL 60607 312.836.0050 Cell: 312.399.2894 Worth reading: killianbranding.com/whitepapers Blog: killianbranding.com/blog

Leave a Reply

Archives

Conversation Across the Site

  • priyavanjeri { I absolutely agree with you. Governments are constantly criticizing pharma companies for shooting up prices but instead should divery their energy and resources towards developing... } – Pharmaceutical Pricing, Markets and Ebola
  • Fabio { How Pharmaceutical companies can help? Check it here http://online.wsj.com/articles/johnson-johnson-to-begin-testing-ebola-vaccine-in-january-1413957003 If we didn't need those companies, why government agencies and Universities didn't work on a solution... } – Pharmaceutical Pricing, Markets and Ebola
  • manishaaithal1 { PM Mr. Modi has made a impact in his tenure of state chief minister of Gujarat, has taken state leadership scope to a newer level.... } – Rebranding India
  • manishaaithal1 { Ebola outbreak is best example to re-state that healthcare can not be treated with mere wealth generation / business creation motive. Healthcare needs to be... } – Pharmaceutical Pricing, Markets and Ebola
  • Andrei Mitran { National rebranding - I admire the brave move. However, I do not think there are any quick rebranding alternatives for Prime Minister Modi. Investors wil... } – Rebranding India
  • David { I understand the rational but I am not sure it is completely built on facts ... The fact that on one hand many pharmaceuticals companies... } – Pharmaceutical Pricing, Markets and Ebola
  • Read more Comments »

Collaborate with Tim

Tim helps companies around the world build great brands. To schedule a program or event click here. To learn more about Tim’s books, click here.